AI/ ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective.
FDA has regulated medical software by means of regulations and guidance for years, however, AI/ML programs fall outside the scope of these regulations and guidances.
This happens because FDA approves the final, validated version of the software. The point of AI/ML is to learn and update following deployment to improve performance. Thus the field version of the software is no longer the validated approved version.
We will discuss the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future. Your development program should conform to these concepts now because, with some modifications, they will probably become regulations.
Following a discussion of possible future regulations, we will discuss, based on recently approved De Novo applications, how to get your AI/ML program approved now. Necessary submission documentation will be explained.
This webinar is not a programming course but will explain the present and future regulatory requirements for AI/ML.
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
Edwin Waldbusser
Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Interactive dashboards & analytics in Excel
Language is Code - Intro to AI - Generative AI - ChatGPT an…
Medical Device Hazard analysis following ISO 14971
Data Integrity and Privacy: Compliance with 21 CFR Part 11,…
FDA Audit Best Practices - Do's and Don'ts
Performance of Root Cause Analysis, CAPA, and Effectiveness…
Unauthorized Transactions – Reg E vs Nacha Operating Rules
Secrets Of Psychology - Why People Do The Things They Do
New Form I-9: Documents and Policies that Ensure ICE I-9 Co…
2-Hour Virtual Seminar on How to Conduct an Internal Harass…
Claude AI For CPAs & Finance Professionals: Best Practices …
Managing Complex Projects - Project Management
Project Management For Administrative Professionals
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
Onboarding is NOT Orientation - How to Improve the New Empl…
Negotiating Skills For Professional Results - Winning Strat…
Utilizing HR Metrics to Illustrate & Improve Human Resource…
NEW Nacha Rule - Third-Party Sender (TPS) Roles and Respons…
FDA Technology Modernization Action Plan (TMAP) and Impact …
Paying and Receiving Payments for Referrals: You Can Go to …
Validation Statistics for Non-Statisticians
Construction Lending And Real Credit Administration: Evalua…
Human Factors Usability Studies Following ISO 62366 and FDA…
Thriving in a Hybrid Workplace: Keys to Leadership and Team…
Excel Power Skills: Master Functions, Formulas, and Macros …